Imaging Characteristics of Oligodendrogliomas That Predict Grade
Authors:
Open Access
- 19 January 2012
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 33 (5) , 852-857
Abstract
BACKGROUND AND PURPOSE: Oligodendrogliomas are tumors that have variable WHO grades depending on anaplasia and astrocytic components and their treatment may differ accordingly. Our aim was to retrospectively evaluate imaging features of oligodendrogliomas that predict tumor grade. MATERIALS AND METHODS: The imaging studies of 75 patients with oligodendrogliomas were retrospectively reviewed and compared with the histologic grade. The presence and degree of enhancement and calcification were evaluated subjectively. rCBV and ADC maps were measured. Logistic linear regression models were used to determine the relationship between imaging factors and tumor grade. RESULTS: Thirty of 75 (40%) tumors enhanced, including 9 of 46 (19.6%) grade II and 21 of 29 (72.4%) grade III tumors (P < .001). Grade III tumors showed lower ADC values compared with grade II tumors (odds ratio of a tumor being grade III rather than grade II = 0.07; 95% CI, 0.02–0.25; P = .001). An optimal ADC cutoff of 925 10−6 mm2/s was established, which yielded a specificity of 89.1%, sensitivity of 62.1%, and accuracy of 78.7%. There was no statistically significant association between tumor grade and the presence of calcification and perfusion values. Multivariable prediction rules were applied for ADC < 925 10−6 mm2/s, the presence of enhancement, and the presence of calcification. If either ADC < 925 10−6 mm2/s or enhancement was present, it yielded 93.1% sensitivity, 73.9% specificity, and 81.3% accuracy. The most accurate (82.2%) predictive rule was seen when either ADC < 925 10−6 mm2/s or enhancement and calcification were present. CONCLUSIONS: Models based on contrast enhancement, calcification, and ADC values can assist in predicting the grade of oligodendrogliomas and help direct biopsy sites, raise suspicion of sampling error, and predict prognosis.Keywords
This publication has 34 references indexed in Scilit:
- Identification of calcification with MRI using susceptibility‐weighted imaging: A case studyJournal of Magnetic Resonance Imaging, 2008
- Time Trends in Oligodendroglial and Astrocytic Tumor IncidenceNeuroepidemiology, 2008
- Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imagingJournal of Neurosurgery, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial TumorsAmerican Journal of Roentgenology, 2007
- Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade GliomasNeurosurgery, 2006
- Prognostic value of perfusion-weighted imaging in brain glioma: a prospective studyActa Neurochirurgica, 2006
- Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imagingJournal of Neurosurgery, 2004
- Oligodendrogliomas: A comparison of CT and MR imaging features with histological malignancy grading in 20 cases: A pathoradiological studyActa Radiologica, 2002
- Oligodendrogliomas in the CT/MR-EraActa Neurochirurgica, 2001